A phase 2a trial of the IL-33 monoclonal antibody tozorakimab in patients with COPD: FRONTIER-4
一项针对慢性阻塞性肺病患者的IL-33单克隆抗体tozorakimab的2a期临床试验:FRONTIER-4
期刊:European Respiratory Journal
影响因子:21
doi:10.1183/13993003.02231-2024
Singh, Dave; Guller, Patricia; Reid, Fred; Doffman, Sarah; Seppälä, Ulla; Psallidas, Ioannis; Moate, Rachel; Smith, Rebecca; Kiraga, Joanna; Jimenez, Eulalia; Brooks, Dennis; Kelly, Aoife; Nordenmark, Lars H; Sadiq, Muhammad Waqas; Caballero, Luis Mateos; Kell, Chris; Belvisi, Maria G; Pandya, Hitesh